Tag Archives: FLEX trial
Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression
Good news for patients with non-small-cell lung cancer (NSCLC)! If you have NSCLC, you might like to ask your oncologist to check whether you have high expression of EGFR. Patients with high EGFR expression represented about 25 percent of people … Continue reading
Posted in Lung Cancer, Non Small Cell Lung Cancer
Tagged Cetuximab, EGFR, Erbitux, FLEX trial, Non small cell lung cancer, NSCLC, Survival
Comments Off on Cetuximab Increases Survival in Patients with Lung Cancer with High EGFR Expression